Almac Discovery

Almac Discovery is a leading contract research organisation (CRO) based in the UK, dedicated to advancing drug discovery and development. With a strong focus on innovation, Almac Discovery provides a comprehensive range of services that support pharmaceutical and biotechnology companies in their quest to bring new therapies to market.

Founded with a vision to enhance the efficiency of drug development, Almac Discovery offers expertise in areas such as biomarker discovery, assay development, and clinical trial support. The company prides itself on its state-of-the-art facilities and a team of highly skilled scientists who are committed to delivering high-quality results.

One of the key strengths of Almac Discovery is its collaborative approach, working closely with clients to tailor solutions that meet their specific needs. This partnership model not only fosters innovation but also accelerates the drug development process, ultimately benefiting patients worldwide.

In addition to its core services, Almac Discovery is actively involved in research initiatives aimed at discovering novel therapeutic targets and developing cutting-edge technologies. The company’s commitment to scientific excellence is reflected in its robust quality assurance processes and adherence to regulatory standards.

Almac Discovery is also dedicated to sustainability and corporate social responsibility, striving to minimize its environmental impact while contributing positively to the communities it serves.

Core Services:

• Biomarker Discovery
• Assay Development
• Clinical Trial Support
• Research Initiatives

With a growing portfolio of successful projects and a reputation for reliability, Almac Discovery continues to be a trusted partner in the life sciences sector, driving forward the future of healthcare.